{"id":"https://openalex.org/W7204018843","doi":null,"title":"Daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitable: a single technology appraisal","display_name":"Daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitable: a single technology appraisal","publication_year":2025,"publication_date":"2025-01-01","ids":{"openalex":"https://openalex.org/W7204018843"},"language":"en","primary_location":{"id":"pmh:oai:eprints.soton.ac.uk:513446","doi":null,"is_oa":false,"landing_page_url":"https://eprints.soton.ac.uk/id/eprint/513446/1/Daratumumab_ID3843_EAG_report.pdf","pdf_url":"https://eprints.soton.ac.uk/id/eprint/513446/1/Daratumumab_ID3843_EAG_report.pdf","source":{"id":"https://openalex.org/S4306401019","display_name":"ePrints Soton (University of Southampton)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I43439940","host_organization_name":"University of Southampton","host_organization_lineage":["https://openalex.org/I43439940"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Monograph"},"volume":null,"type":"book","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015678366","display_name":"Neelam Kalita","orcid":"https://orcid.org/0000-0002-0973-0160","observed_orcids":["https://orcid.org/0000-0002-0973-0160"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kalita, Neelam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055736870","display_name":"Lois Woods","orcid":"https://orcid.org/0000-0002-4587-9149","observed_orcids":["https://orcid.org/0000-0002-4587-9149"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Woods, Lois","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060493962","display_name":"Fay Chinnery","orcid":"https://orcid.org/0000-0002-8082-9016","observed_orcids":["https://orcid.org/0000-0002-8082-9016"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chinnery, Fay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123348224","display_name":"David Alexander Scott","orcid":"https://orcid.org/0000-0001-6475-8046","observed_orcids":["https://orcid.org/0000-0001-6475-8046"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott, David Alexander","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5101471532","display_name":"Jonathan Shepherd","orcid":"https://orcid.org/0000-0003-1682-4330","observed_orcids":["https://orcid.org/0000-0003-1682-4330"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shepherd, Jonathan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.9900000095367432},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.996999979019165},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":1.0},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":1.0},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.871999979019165},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5389999747276306},{"id":"https://openalex.org/keywords/technology-appraisal","display_name":"technology appraisal","score":0.5789999961853027},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.3009999990463257}],"concepts":[{"id":"https://openalex.org/C2781119759","wikidata":"https://www.wikidata.org/wiki/Q5222113","display_name":"Daratumumab","level":4,"score":0.9438999891281128},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.8759999871253967},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.8098000288009644},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7741000056266785},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.7353000044822693},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6427000164985657},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6011000275611877},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.517300009727478},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.31310001015663147},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.3098999857902527},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.2946999967098236},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.29339998960494995},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2838999927043915},{"id":"https://openalex.org/C2779050716","wikidata":"https://www.wikidata.org/wiki/Q4826373","display_name":"Autologous stem-cell transplantation","level":3,"score":0.26010000705718994}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:eprints.soton.ac.uk:513446","doi":null,"is_oa":false,"landing_page_url":"https://eprints.soton.ac.uk/id/eprint/513446/1/Daratumumab_ID3843_EAG_report.pdf","pdf_url":"https://eprints.soton.ac.uk/id/eprint/513446/1/Daratumumab_ID3843_EAG_report.pdf","source":{"id":"https://openalex.org/S4306401019","display_name":"ePrints Soton (University of Southampton)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I43439940","host_organization_name":"University of Southampton","host_organization_lineage":["https://openalex.org/I43439940"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Monograph"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8560000061988831}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6990240278","https://openalex.org/W4413791500","https://openalex.org/W2936318869","https://openalex.org/W7204481434","https://openalex.org/W4414302812","https://openalex.org/W2780041189","https://openalex.org/W7033131454","https://openalex.org/W7212512756","https://openalex.org/W3049547584","https://openalex.org/W7018319157"],"abstract_inverted_index":{"This":[0],"report":[1],"critiques":[2],"the":[3],"company":[4],"submission":[5],"for":[6,14],"daratumumab":[7],"with":[8],"bortezomib,":[9],"lenalidomide":[10],"and":[11],"dexamethasone":[12],"(DBLd)":[13],"untreated":[15],"multiple":[16],"myeloma":[17],"when":[18],"a":[19],"stem":[20],"cell":[21],"transplant":[22],"is":[23],"unsuitable.":[24]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2026-08-23T00:00:00"}